| Followers | 310 |
| Posts | 77948 |
| Boards Moderated | 4 |
| Alias Born | 02/16/2008 |
Thursday, July 28, 2016 9:48:40 AM
FATE is Rockin
Yesssssssssssss
Yesssssssssssss
Recent FATE News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/24/2026 08:09:40 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 08:08:03 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 08:03:55 PM
- Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annua • GlobeNewswire Inc. • 04/16/2026 01:00:00 PM
- Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences • GlobeNewswire Inc. • 04/09/2026 01:00:00 PM
- Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/02/2026 08:05:00 PM
- The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed • GlobeNewswire Inc. • 03/18/2026 03:30:00 PM
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/04/2026 09:05:00 PM
- Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference • GlobeNewswire Inc. • 03/03/2026 09:05:00 PM
- Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them • PR Newswire (Canada) • 03/03/2026 03:02:00 PM
- Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them • PR Newswire (US) • 03/03/2026 03:02:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 02:07:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 02:04:07 PM
- Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 02/26/2026 02:00:00 PM
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/03/2026 09:05:00 PM
- Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets • PR Newswire (Canada) • 01/26/2026 03:16:00 PM
- Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets • PR Newswire (US) • 01/26/2026 03:16:00 PM
- Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets • GlobeNewswire Inc. • 01/23/2026 05:56:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:03:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:02:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:00:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 09:04:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 09:03:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/09/2026 08:08:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/09/2026 08:08:01 PM

